title: Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
abstract: Ten hairy-cell leukemia patients were treated with interferon beta (IFN-beta) at a dose rate of 2 x 10(6) IU/m2 x 5 days for 4 weeks (induction therapy) and, thereafter, at the same dose three times a week for 11 months (maintenance therapy). The effect of this treatment on serum neopterin, beta 2-microglobulin, (2'-5')oligoadenylate [(2'-5')An] levels, intracellular (2'-5')An values and human Mx protein synthesis was analysed. There were significant rises in serum neopterin and (2'-5')An levels during both induction and maintenance, whereas beta 2-microglobulin levels rose only during induction. Rises in intracellular (2'-5')An were documented mainly during induction, but they were not significantly higher than pretherapy values. IFN beta provoked an increase in human Mx protein synthesis over the entire induction-maintenance period, but was only significantly higher than baseline during induction. All markers proved useful for monitoring the effects of IFN beta dose schedules, but were not predictive of clinical outcome. Natural killer activity and IFN gamma production, which were initially defective, followed a different trend from that of the other factors studied, in that increases were documented only late in the course of therapy when the disease was already in remission.
authors.affiliation: Istituto di Clinica Medica Ia-Policlinico Monteluce, Perugia, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Liberati
authors.forename: M
authors.initials: M
authors.lastname: Horisberger
authors.forename: M
authors.initials: M
authors.lastname: Schippa
authors.forename: F
authors.initials: F
authors.lastname: Di Clemente
authors.forename: M
authors.initials: M
authors.lastname: Fizzotti
authors.forename: S
authors.initials: S
authors.lastname: Filippo
authors.forename: M G
authors.initials: MG
authors.lastname: Proietti
authors.forename: S
authors.initials: S
authors.lastname: Arzano
authors.forename: P
authors.initials: P
authors.lastname: Berruto
authors.forename: L
authors.initials: L
authors.lastname: Palmisano
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood; D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D001708:Biopterins / Q000031:analogs & derivatives / Q000097:blood; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D007943:Leukemia, Hairy Cell / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D015703:Antigens, CD; D001613:beta 2-Microglobulin; D001708:Biopterins; D019798:Neopterin; D016899:Interferon-beta; D015088:2',5'-Oligoadenylate Synthetase